| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/06/2001 | CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | CA2410903A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | CA2410895A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410882A1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof |
| 12/06/2001 | CA2410865A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410736A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | CA2410735A1 Use of adnf for enhancing learning and memory |
| 12/06/2001 | CA2410624A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 12/06/2001 | CA2410589A1 Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethylene)cytidine |
| 12/06/2001 | CA2410516A1 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 12/06/2001 | CA2410514A1 Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways |
| 12/06/2001 | CA2410489A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | CA2410485A1 Thrombospondin-1 type 1 repeat polypeptides |
| 12/06/2001 | CA2410480A1 Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
| 12/06/2001 | CA2410470A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | CA2410453A1 Neuroprotective peptides |
| 12/06/2001 | CA2410436A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/06/2001 | CA2410419A1 Improved methods of transfection |
| 12/06/2001 | CA2410087A1 Mammalian protein phosphatases identified by in-silico analysis |
| 12/06/2001 | CA2410084A1 Transporters and ion channels |
| 12/06/2001 | CA2410033A1 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 12/06/2001 | CA2409932A1 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer |
| 12/06/2001 | CA2409597A1 Protein kinase inhibitors |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/06/2001 | CA2408103A1 Tumor activated prodrug compounds and methods of making and using the same |
| 12/06/2001 | CA2406979A1 Indole derivatives with vascular damaging activity |
| 12/06/2001 | CA2383432A1 Therapeutic immune condition compositions and methods |
| 12/05/2001 | EP1160323A1 5T4 tumour-associated antigen for use in tumour immunotherapy |
| 12/05/2001 | EP1160322A2 Human melanocyte stimulating hormone receptors |
| 12/05/2001 | EP1160320A1 Use of hTAFII80 and isoforms thereof for inducing apoptosis |
| 12/05/2001 | EP1160319A2 Antisense-oligonucleotides for the treatment of immunosuppressive effects of transforming growth factor-beta (TGF-beta) |
| 12/05/2001 | EP1160255A1 Monovalent antibody fragments |
| 12/05/2001 | EP1160254A1 Human vanilloid receptor-like proteins |
| 12/05/2001 | EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists |
| 12/05/2001 | EP1160240A1 Guanylhydrazones for treating inflammatory conditions |
| 12/05/2001 | EP1159975A2 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159974A1 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159967A1 Tumor vaccines |
| 12/05/2001 | EP1159963A1 Composition for and method of preventing or treating breast cancer |
| 12/05/2001 | EP1159961A2 Treatment of tumors with compounds having RxR retinoid receptor agonist activity |
| 12/05/2001 | EP1159756A2 Compounds for the treatment of cancer |
| 12/05/2001 | EP1159455A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 12/05/2001 | EP1159431A2 Human kallikrein-like genes |
| 12/05/2001 | EP1159422A1 Compositions and methods for the treatment of tumors |
| 12/05/2001 | EP1159420A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 12/05/2001 | EP1159417A2 Polynucleotides and proteins encoded thereby |
| 12/05/2001 | EP1159328A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 12/05/2001 | EP1159300A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 12/05/2001 | EP1159296A1 METHOD FOR PRODUCING CYCLO-(Asp-DPhe-NMeVal-Arg-Gly) |
| 12/05/2001 | EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta |
| 12/05/2001 | EP1159284A1 33 human secreted proteins |
| 12/05/2001 | EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors |
| 12/05/2001 | EP1159261A2 Antizyme modulators and their use |
| 12/05/2001 | EP1159012A1 Encapsulated cells containing an amplified expression vector as a drug delivery device |
| 12/05/2001 | EP1159008A1 Agents to increase the uptake of pharmaceuticals and diagnostic substances into solid tumors |
| 12/05/2001 | EP1159006A2 Water-soluble compositions of bioactive lipophilic compounds |
| 12/05/2001 | EP1159004A1 Novel redox clamping agents and uses thereof |
| 12/05/2001 | EP1158996A1 Novel amide derivatives as growth hormone secretagogues |
| 12/05/2001 | EP1158993A1 Bacterial membrane fractions with adjuvant effect |
| 12/05/2001 | EP1158986A1 Protease inhibitors |
| 12/05/2001 | EP1158984A1 Inhibitors of prenyl-protein transferase |
| 12/05/2001 | EP1158983A1 Inhibitors of prenyl-protein transferase |
| 12/05/2001 | EP1158982A2 Inhibitors of prenyl-protein transferase |
| 12/05/2001 | EP1158958A1 Improved powdery pharmaceutical compositions for inhalation |
| 12/05/2001 | EP1146050A9 Remedies |
| 12/05/2001 | EP0939765B1 Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage) |
| 12/05/2001 | EP0937036B1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 12/05/2001 | EP0835263B1 Somatostatin peptides |
| 12/05/2001 | EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors |
| 12/05/2001 | EP0769056B1 NON-SPLICING VARIANTS OF gp350/220 |
| 12/05/2001 | EP0745075B1 6-substituted mycophenolic and derivatives with immunosuppressive activity |
| 12/05/2001 | EP0745071B1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity |
| 12/05/2001 | EP0445255B2 USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER |
| 12/05/2001 | CN1325534A Apparatus and method for brachytherapy |
| 12/05/2001 | CN1325450A Adenovirus-mediated gene therapy |
| 12/05/2001 | CN1325442A Endothelial cell proliferation inhibitors derived from human prothrombin |
| 12/05/2001 | CN1325441A Modified exosomes and uses |
| 12/05/2001 | CN1325407A Platelet-derived growth factor D, DNA coding therefor and uses thereof |
| 12/05/2001 | CN1325393A Method for producing luteolin and luteolin derivatives |
| 12/05/2001 | CN1325390A 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/05/2001 | CN1325389A 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/05/2001 | CN1325385A Gastrin and cholecystokinin receptor ligands |
| 12/05/2001 | CN1325384A Anthranilic acid amides and the use thereof as medicaments |
| 12/05/2001 | CN1325315A Implant with cavities containing therapeutic agents |
| 12/05/2001 | CN1325305A Method of administering camptothecin compounds for the treatment of cancer with reduced side effects |
| 12/05/2001 | CN1325303A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses |
| 12/05/2001 | CN1325299A Orally administered controlled drug delivery system providing temporal and spatial control |
| 12/05/2001 | CN1325284A Method for improved imaging and photodynamic therapy |
| 12/05/2001 | CN1325271A Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 12/05/2001 | CN1324951A High-efficiency expression and application of human recombinant interferon B |
| 12/05/2001 | CN1324946A New polypeptide human ATP dependent RNA unwinding enzyme 11 and polynucleotides for encoding same |
| 12/05/2001 | CN1324943A New polypeptide DNA and DEAH cassette family ATP-dependent unwinding enzyme 50 and polynucleotides for encoding same |
| 12/05/2001 | CN1324936A New polypeptide human peroxisome fatty acid acetyl-CoA oxidase 46.97 and polynucleotides for encoding same |
| 12/05/2001 | CN1324859A New polypeptide human ceratin 45.87 and polynucleotides for encoding same |
| 12/05/2001 | CN1324827A New polypeptide DNA mismatch repair protein 10 and polynucleotides for encoding same |
| 12/05/2001 | CN1324823A New polypeptide proliferating cell nuclear antigen (PCNA) 13 and polynucleotides for encoding same |
| 12/05/2001 | CN1324807A New polypeptide ribosome L39 protein 13 and polynucleotides for encoding same |
| 12/05/2001 | CN1324798A Synthesis of mannitose-glucose tetrasaccharide repeated unit with anti-tumor activity |
| 12/05/2001 | CN1324648A Quick-acting gastropathy treating medicine powder and its prepn. |